Landaas & Company’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$704K Hold
2,771
0.13% 60
2026
Q1
$677K Buy
2,771
+157
+6% +$36.6K 0.15% 53
2025
Q4
$541K Sell
2,614
-24
-0.9% -$4.75K 0.12% 59
2025
Q3
$489K Buy
2,638
+240
+10% +$41.1K 0.11% 55
2025
Q2
$366K Buy
2,398
+555
+30% +$85.3K 0.09% 69
2025
Q1
$306K Hold
1,843
0.08% 71
2024
Q4
$267K Sell
1,843
-82
-4% -$12.7K 0.07% 68
2024
Q3
$312K Buy
1,925
+1
+0.1% +$159 0.09% 60
2024
Q2
$281K Buy
1,924
+101
+6% +$15K 0.09% 62
2024
Q1
$288K Sell
1,823
-18
-1% -$2.87K 0.09% 61
2023
Q4
$289K Sell
1,841
-1,121
-38% -$172K 0.11% 55
2023
Q3
$461K Sell
2,962
-91
-3% -$15K 0.2% 35
2023
Q2
$505K Buy
3,053
+15
+0.5% +$2.42K 0.22% 32
2023
Q1
$471K Buy
3,038
+499
+20% +$80.6K 0.23% 31
2022
Q4
$448K Sell
2,539
-1,074
-30% -$185K 0.25% 31
2022
Q3
$590K Sell
3,613
-172
-5% -$29.1K 0.37% 22
2022
Q2
$672K Buy
3,785
+1
+0% +$178 0.41% 19
2022
Q1
$647K Hold
3,784
0.34% 25
2021
Q4
$647K Buy
3,784
+1
+0% +$164 0.34% 25
2021
Q3
$611K Buy
3,783
+45
+1% +$7.68K 0.35% 24
2021
Q2
$616K Buy
3,738
+8
+0.2% +$1.32K 0.34% 28
2021
Q1
$613K Buy
3,730
+7
+0.2% +$1.13K 0.37% 25
2020
Q4
$586K Buy
3,723
+8
+0.2% +$1.18K 0.4% 22
2020
Q3
$553K Sell
3,715
-193
-5% -$28.6K 0.42% 20
2020
Q2
$550K Buy
3,908
+7
+0.2% +$1.02K 0.44% 23
2020
Q1
$570K Sell
3,901
-119
-3% -$16.9K 0.48% 22
2019
Q4
$586K Buy
4,020
+1,007
+33% +$137K 0.41% 24
2019
Q3
$390K Sell
3,013
-149
-5% -$19.6K 0.29% 31
2019
Q2
$440K Buy
3,162
+1
+0% +$138 0.31% 28
2019
Q1
$442K Hold
3,161
0.32% 30
2018
Q4
$408K Sell
3,161
-250
-7% -$34.9K 0.34% 30
2018
Q3
$471K Sell
3,411
-175
-5% -$23.3K 0.37% 30
2018
Q2
$435K Sell
3,586
-100
-3% -$12.5K 0.35% 27
2018
Q1
$472K Sell
3,686
-150
-4% -$20.3K 0.48% 25
2017
Q4
$536K Sell
3,836
-728
-16% -$101K 0.46% 22
2017
Q3
$593K Buy
+4,564
New +$605K 0.52% 17

Other funds holding JNJ

Landaas & Company's JNJ Position: Q2 2026 in Review

Landaas & Company held its Johnson & Johnson (JNJ) position steady in Q2 2026 at 2,771 shares worth $704K. The position accounts for 0.13% of the portfolio, ranked #60.

Landaas & Company first reported a position in JNJ in Q3 2017 and has held it in 36 quarters since. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Landaas & Company held 2,771 shares of Johnson & Johnson worth $704K as of Q2 2026.
  • Landaas & Company left its Johnson & Johnson share count unchanged in Q2 2026.
  • Johnson & Johnson made up 0.13% of Landaas & Company's portfolio in Q2 2026, its #60 holding.
  • Landaas & Company first reported a position in Johnson & Johnson in Q3 2017 and has held it in 36 quarters since.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Landaas & Company's 13F filing for Q2 2026, filed 21 Jul 2026.